the mature T cells from the donated marrow. 2 This approach has subsequently been successful in over half of the transplanted children with SCID. Graft failure is much Bone marrow transplantation is the only curative treatment for children with severe combined immunodefiless common in children than in older leukaemic patients given similarly treated marrow perhaps because children ciency (SCID). In the absence of an HLA-identical sibling, haploidentical parental donor marrow can be used with SCID lack the alloreactive immune responses that mediate graft rejection.
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provided it is depleted of T cells to prevent otherwise inevitable GVHD. Campath 1M has been successfully T cell depletion has been accomplished by a variety of methods including physical separation with soya bean lecused for this procedure in several centres. In our centre 17 SCID patients plus one with combined immunodefitin and sheep erythrocyte rosetting, 6 as well as immunochemical methods using monoclonal antibodies to lymphocyte ciency (CID) were transplanted with Campath 1M T cell-depleted bone marrow. Progenitor cell recovery, surface antigens, such as Campath 1M in vitro and Campath 1G added to the bag of donor marrow or infused in before and after T cell depletion, was monitored using granulocyte-macrophage colony-forming cell assays vivo. 7, 8 We describe a series of 18 T cell-depleted transplants carried out in our BMT centre over the past 8 years, (GMCFU) and CD34 analysis. The numbers of GMCFU/kg transplanted correlated with engraftment during which time the method of marrow manipulation during T cell depletion was changed in an attempt to conform and survival post-transplant and monitoring CD34
+ cell numbers in the T cell-depleted marrow pretransplant with other European centres who mainly used physical methods of T cell depletion. Unfortunately this change may be an additional indicator of successful engraftment. Use of a buffy coat marrow preparation appeared to contribute to several failures of engraftment. We therefore attempted to identify markers that would prewith restriction of the number of T cells to Ͻ5 × 10 5 /kg was associated with graft failure in four and death in dict lymphoid engraftment and our results suggest that the number of both CD34 + cells and GMCFU infused per kg five of eight children, probably because too few stem cells were infused. T cell depletion of a mononuclear cell correlates with sustained engraftment and survival following T cell-depleted donor marrow transplantation in preparation of donor marrow with no arbitrary ceiling of infused T cells is highly effective at preventing clinipatients with SCID. cally important GVHD and cured nine out of 10 children transplanted with such material. Keywords: T cell depletion; severe combined immuno-
Materials and methods deficiency Patients
Between 1986 and 1996, 18 children were given T cellReplacement of the immune system by bone marrow transdepleted transplants. Seventeen had SCID and one a T cell plantation (BMT) is the only curative treatment for severe activation disorder, Zap 70 kinase deficiency. Five children combined immunodeficiency (SCID) and was first successreceived second transplants. In 17 children, marrow was fully performed using an HLA identical sibling donor in obtained from a one haplotype mismatched parent. The 1968.
1 Unfortunately only 20% of affected children have child with T cell activation defect received marrow from an HLA identical sibling and the urgent need for BMT an unrelated, HLA phenotypically matched donor. ( Table 1) were reduced to mononuclear cell (MNC) popuSince differential counts (and therefore no mononuclear cell counts) were not recorded on the BC fractions, and since lations by Ficoll density centrifugation using a COBE IBM 2991 (Cobe Laboratories, Gloucester, UK) cell separator as an aliquot of the T cell-depleted material was subjected to Ficoll separation before plating out we needed a method of described by Gilmore et al 9 before T cell depletion. In the remaining cases (patients 5-12) a red cell-depleted buffy directly comparing the doses of GMCFU given to each patient from the two different methods of preparation. In coat (BC) was used for T cell depletion. One or two rounds of donor complement were used after incubation with Camorder to compare like with like the dose of GMCFU was therefore calculated for both groups of patients from the path 1M. Those receiving T cell-depleted MNC were given all the residual marrow. Those given T cell-depleted BC white blood cell (WBC) count and proportion of gated 'lymphocytes' recorded during FACS analysis of CD34 and were restricted, when possible, to that quantity of marrow which contained a maximum of 5 × 10 5 CD3 + T cells/kg CD3 populations before and after T cell depletion. Such calculations assume that the gated 'lymphocytes' are equivand 5 × 10 8 or more WBC/kg body weight. When it is impossible to achieve both levels together, the more correct alent to the mononuclear cells obtained after separation over Ficoll and which were plated out for the GMCFU number of T cells was given at the expense of giving a low mononuclear cell dose. In all other respects the handling assays. In the case of T cell-depleted MNC preparations a much more direct calculation of GMCFU dose was also of the marrow was identical in both groups.
possible calculated from the number of cells plated, colonies per 10 5 and total cells transfused.
Progenitor cell assays
Standard double-layer agar or 0.9% methyl cellulose assays CD3 and CD34/CD45RA analysis (containing 100 units rGCSF (Amgen, Cambridge, UK)) were used to measure granulocyte/macrophage colony-for-T cell-depleted and -undepleted bone marrow was analysed by flow cytometry using phycoerytherin (PE)-conjugated or ming units (GMCFU).
10 Samples of marrow were tested immediately prior to T cell depletion and after the final fluorescein (FITC)-conjugated anti-CD3, CD34 (QBend 10) and CD45RA antibodies (Becton Dickinson, San Jose, CA, wash. In order that BC preparations of marrow could be directly compared with MNC, the BC preparations were USA). Analysis of the CD34 + population was carried out as described by Sutherland et al 11 using double-labelled reduced to mononuclear cell fractions over Ficoll, before and after T cell depletion, prior to plating out for colony immunofluorescence with PE-and FITC-labelled anti-CD34 and anti-CD45RA + antibodies, respectively. At least assays. Colonies comprising Ͼ40 cells were scored after 14 days culture. Results were expressed as GMCFU/10 5 50 000 events were analysed and the results expressed as CD34 × 10 6 /kg or CD34 percentage in BC or MNC fracplated cells and as absolute GMCFU × 10 4 /kg body weight.
tions. CD3-positive T cells were expressed as CD3 × 10 5 /kg. Limiting dilution analysis 12 demonstrated a 2-3 log depletion of T cells in the final preparations (data not shown).
Assessment of engraftment and immune reconstitution
Engraftment was assessed according to standard criteria: days to neutrophil count of 0.5 × 10 9 /l, and to platelet count of 50 × 10 9 /l. Laboratory criteria of immune reconstitution was assessed by measuring (1) months to T cell (CD3 + ), or days to B cell (CD19), and NK cell (CD16) counts of 
Correlation between GMCFU recoveries, GMCFU/kg Experimental in vitro comparison between T cell-depleted transfused and clinical outcome buffy coat and T cell-depleted mononuclear cell fractions
GMCFU × 10 4 /kg pre-and post-T cell depletion for MNC and BC preparations were analysed for 12/18 SCID transSince our clinical results suggested a greater loss of proplants and are shown in Table 2 . For comparative purposes genitors using a BC T cell depletion method we compared these results are based on the percentage lymphocyte popuboth MNC and BC methods using the same normal donor lations within both BC and MNC fractions (see Materials marrow, batch of Campath 1M and complement source. and methods). A significant loss of GMCFU × 10 4 /kg was Five normal marrows were tested. BC samples were preobserved using either procedure. However, this was more pared by centrifuging the marrow at 1000 r.p.m. for 10 min noted in the BC fractions (p = 0.005) than in the MNC using a bench top centrifuge. In order to assess progenitor fractions (P = 0.01). Although the loss of GMCFU × 10 4 /kg cell content, part of the BC fraction was further separated was striking in the BC group, the GMCFU content of marover Ficoll to obtain a mononuclear cell fraction which was row which was available for transfusion was not signifiused for GMCFU assays and CD34% estimations pre-and cantly different from the MNC fraction (0.98 Ϯ 1.1 vs post-T cell depletion of the BC. The MNC fractions for T 0.45 Ϯ 0.2 × 10 4 /kg, P = 0.4). In the BC T cell-depleted cell depletion were obtained by separating a BC fraction group, however, the quantity of marrow transfused was over Ficoll, using a bench top centrifuge and the MNC fracrestricted to that volume with 5 × 10 5 kg or less CD3 + T tion obtained used for T cell depletion and analysis of procells and or 5 × 10 8 /kg WBC and was significantly different genitor cell content. All Campath 1M and complement confrom the MNC fraction transfused (0.98 ± 1.1 vs centrations were adjusted to be equivalent to those used for 0.2 ± 0.1 × 10 4 /kg, P = 0.03). If the full quantity of BC marpatient donor marrow T cell depletions. The results from row had been transfused the GM-CFU/kg would have been these experiments are expressed as GMCFU/10 5 plated pregreater (0.45 ± 02 vs 0.2 ± 0.1 × 10 4 /kg, P = 0.045). These and post-T cell depletion. Absolute and percentage CD34 + results are shown in Table 2 . The GMCFU × 10 4 /kg dose cell populations were also monitored pre-and post-T cell for the MNC group was also calculated using the total depletion and percentage recovery of cells recorded.
MNC in the T cell-depleted marrow; this result (mean Results from 18/20 pairs of CD34/GMCFU/10 5 analyses 38.8 Ϯ 51.5 × 10 4 /kg, individual data not shown) was simi-(BC = 8; MNC = 10) were correlated and expressed lar to that reported by Gilmore et al 9 using this method of graphically (Figure 1) .
T cell depletion for SCID transplants and was obviously higher than that calculated using lymphocytes alone. Five of six evaluable patients (four BC; one MNC) given low numbers of GMCFU/kg either never engrafted or Statistics needed a second transplant. Engraftment data for these patients is shown in Table 3 . The majority of patients The non-parametric Mann-Whitney U test was used to anareceiving T cell-depleted BC (6/8) remained platelet depenlyze pre-and post-T cell depletion GMCFU content of the dent post-transplant. Clinically important GVHD (grade II donor marrow and the Spearman rank correlation used to or above) occurred in four of eight patients given BC marcorrelate CD34 percentage data with GMCFU/10 5 cells row and in none of the 10 given MNC marrow, even though the number of T cells infused was low in these BC cases plated. /kg given using the total MNC count in this group of patients was 38.8 Ϯ 51.7 × 10 4 /kg (individual data not shown) (see Materials and methods), and for comparative purposes with the BC fraction the GMCFU × 10 4 /kg quoted as the post set of data was the dose transfused. b GMCFU × 10 4 /kg were calculated using the absolute number of 'lymphocytes' in the harvested marrow pre-and post-T cell depletion (see Materials and methods). c Patients 6, 9, 10, 11 needed second or third (No. 12) transplant. Patients 6, 8, 10, 11 and 17 died (see Table 3 ).
Table 3
Engraftment data: SCID + CID (n = 1) patients Cause of death: 1 and 6 = Parainfluenza III pneumonitis; 2 = Parainfluenza I pneumonitis; 3 = RSV pneumonitis; 4 = M/F GVHD/pulmonary complications; 5 = Generalized apergillus infections (Nos. 1, 2, 3, 4 and 6 also present at presentation). ND = not done.
(5 × 10 5 , or less, cells/kg in patients 7, 8, 11 and 12). Evi-(patients 7, 9, 12, 13, 14, 15 and 16, Table 3 ). However, of the evaluable patients (n = 10) who survived, the mean dence of immune reconstitution, as determined by days to neutrophil reconstitution, proved to be a poor predictor of GMCFU × 10 4 /kg transfused (0.89 Ϯ 1.08) was significantly higher than the GMCFU × 10 4 /kg given to patients clinical outcome, although platelet independence did seem to predict a successful outcome (Table 3) /kg). In the MNC T cellthere were changes in marrow handling during T cell depletion and the criteria for determining the dose of T depleted group, three patients (Nos 14, 15 and 16) also engrafted with a low (Ͻ1 × 10 6 /kg) CD34/kg cell dose but cells and WBC. Initially (patients 1-4), T cell depletion was carried out on a mononuclear cell preparation of bone adequate GMCFU/kg. It should also be noted that 5/6 of the patients who did not survive died of infections that were marrow cells obtained by separation over Ficoll using the COBE IBM 2991 cell separator. Midway through this proalready established when transplantation was carried out. gramme we introduced a change which involved depleting buffy coat preparations, also prepared on the same cell Experimental comparison of T cell depletion of BC and separator, and limiting the total dose of infused residual T MNC cells when possible to no more than 5 × 10 5 /kg (patients 5-12). This protocol was introduced in 1991 in order to conFive normal bone marrow preparations were separated into BC or MNC fractions pre-and post-T cell depletion.
form to European recommendations put forward at the European Group for Immunodeficiencies (Working Party on GMCFU content and absolute CD34 numbers on the cell fractions used for T cell depletion were assessed. The Bone Marrow Transplantation) for T cell depletion in the transplantation of congenital immune deficiencies. 5 After results are shown in Table 4 and Figure 1 . After T cell depletion using BC and MNC methods similar recovery of the series of eight consecutive 'buffy coat' procedures (patients 5-12), five of which led to death, we reverted to GMCFU (82% and 75% respectively) was achieved. There was no evidence from this in vitro experiment that one our original method of handling and abandoned the 'ceiling' of infused T cells (patients 13-18). method was intrinsically more successful than the other at retaining GMCFU.
The reasons for failure of the BC method were not clear. We wondered whether depletion of BC was associated with When absolute numbers of CD34-positive cells pre-and post-T cell depletion were calculated, the percentage a greater loss of stem cells, but apparent stem cell concentrations, as measured by GMCFU assays and CD34 analyrecoveries in the BC or MNC fractions were 62 Ϯ 15% and 54 Ϯ 9%, respectively (individual data not shown). In these sis, pre-and post-T cell depletion using the same normal marrow, complement, and batch of Campath 1M antibody, experiments we correlated the percentage of CD34 + cells with the GMCFU/10 5 content of cell fractions pre and postwere remarkably similar (BC 82%; MNC 75%), suggesting that the presentation of the material for T cell depletion (ie T cell depletion. The correlation coefficient was 0.63 (P = 0.01) and the results are shown graphically (Figure 1 ). High as BC or MNC) did not per se affect the recovery of stem cells, with the caveat that small-scale bench experiments percentages of CD34 + occasionally did not correspond with higher GMCFU values and conversely low CD34 + levels may not be exactly comparable to the much larger scale manipulations involved in handling a clinical bone marrow did not always correspond with low GMCFU/10 5 .
sample. Furthermore, the correlation (0.6) between the GMCFU and CD34 cell numbers was reasonable but engraftment was possible when low CD34 × 10 6 /kg but Discussion adequate GMCFU × 10 4 /kg were transfused. In several cases the numbers of CD34 x 10 6 /kg obtained, following Eleven of 17 patients followed for Ͼ1 year (64%; 95% confidence interval 38-85%) have been successfully T cell depletion were within the range observed using more recent techniques for T cell depletion including the use of treated, with no deaths from any cause beyond 9 months. This compares favourably with 46-67% survival reported Campath 1G, allogeneic donor peripheral blood stem cell harvesting and subsequent CD34 isolation. 14, 15 It seems from other series around the world, 5-7,13 despite an increased rate of failure to engraft during a period when unlikely therefore that the BC depletion procedure alone was the reason for graft failure. Given, however, the poorer recovery of GMCFU × 10 4 /kg obtained with these trans- Table 4 A comparison of GMCFU colony formation pre-and post-T plants, the effect was compounded by keeping to a protocol cell depletion for both buffy coat (BC) and mononuclear cell (MNC) which suggested a ceiling of 5 × 10 5 /kg T cells; this normal bone marrow preparations. Colonies were counted at day 14 resulted in not transfusing the whole of the buffy coat. A large number of allogeneic transplants (greater than 500) In conclusion, our study suggests that monitoring of pro- of stem cells are given.
